Literature DB >> 23554188

Clostridium difficile ribotype diversity at six health care institutions in the United States.

Sheila Waslawski1, Eugene S Lo, Sarah A Ewing, Vincent B Young, David M Aronoff, Susan E Sharp, Susan M Novak-Weekley, Arthur E Crist, W Michael Dunne, Joan Hoppe-Bauer, Michelle Johnson, Stephen M Brecher, Duane W Newton, Seth T Walk.   

Abstract

Capillary-based PCR ribotyping was used to quantify the presence/absence and relative abundance of 98 Clostridium difficile ribotypes from clinical cases of disease at health care institutions in six states of the United States. Regionally important ribotypes were identified, and institutions in close proximity did not necessarily share more ribotype diversity than institutions that were farther apart.

Entities:  

Mesh：

Year:  2013        PMID： 23554188      PMCID： PMC3716112          DOI： 10.1128/JCM.00056-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  Comparative analysis of an expanded Clostridium difficile reference strain collection reveals genetic diversity and evolution through six lineages.

Authors:  Cornelis W Knetsch; Elisabeth M Terveer; Chris Lauber; Alexander E Gorbalenya; Céline Harmanus; Ed J Kuijper; Jeroen Corver; Hans C van Leeuwen
Journal:  Infect Genet Evol       Date:  2012-06-15       Impact factor: 3.342

2.  Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.

Authors:  Mark Miller; Denise Gravel; Michael Mulvey; Geoffrey Taylor; David Boyd; Andrew Simor; Michael Gardam; Allison McGeer; James Hutchinson; Dorothy Moore; Sharon Kelly
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

3.  Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.

Authors:  Fred C Tenover; Susan Novak-Weekley; Christopher W Woods; Lance R Peterson; Thomas Davis; Paul Schreckenberger; Ferric C Fang; Andre Dascal; Dale N Gerding; Jim H Nomura; Richard V Goering; Thomas Akerlund; Alice S Weissfeld; Ellen Jo Baron; Edith Wong; Elizabeth M Marlowe; Joseph Whitmore; David H Persing
Journal:  J Clin Microbiol       Date:  2010-08-11       Impact factor: 5.948

4.  Clostridium difficile infection in Europe: a hospital-based survey.

Authors:  Martijn P Bauer; Daan W Notermans; Birgit H B van Benthem; Jon S Brazier; Mark H Wilcox; Maja Rupnik; Dominique L Monnet; Jaap T van Dissel; Ed J Kuijper
Journal:  Lancet       Date:  2011-01-01       Impact factor: 79.321

5.  Non-toxigenic Clostridium sordellii: clinical and microbiological features of a case of cholangitis-associated bacteremia.

Authors:  Seth T Walk; Ruchika Jain; Itishree Trivedi; Sylvia Grossman; Duane W Newton; Tennille Thelen; Yibai Hao; J Glenn Songer; Glen P Carter; Dena Lyras; Vincent B Young; David M Aronoff
Journal:  Anaerobe       Date:  2011-06-25       Impact factor: 3.331

6.  Laboratory maintenance of Clostridium difficile.

Authors:  Joseph A Sorg; Sean S Dineen
Journal:  Curr Protoc Microbiol       Date:  2009-02

7.  New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection.

Authors:  S Persson; M Torpdahl; K E P Olsen
Journal:  Clin Microbiol Infect       Date:  2008-11       Impact factor: 8.067

8.  Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007.

Authors:  Adam K Cheknis; Susan P Sambol; David M Davidson; Kristin J Nagaro; Maria C Mancini; G Aida Hidalgo-Arroyo; Jon S Brazier; Stuart Johnson; Dale N Gerding
Journal:  Anaerobe       Date:  2009-09-06       Impact factor: 3.331

9.  Detection of mixed populations of Clostridium difficile from symptomatic patients using capillary-based polymerase chain reaction ribotyping.

Authors:  Adam A Behroozian; Jeffrey P Chludzinski; Eugene S Lo; Sarah A Ewing; Sheila Waslawski; Duane W Newton; Vincent B Young; David M Aronoff; Seth T Walk
Journal:  Infect Control Hosp Epidemiol       Date:  2013-07-12       Impact factor: 3.254

10.  Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR.

Authors:  T Rinttilä; A Kassinen; E Malinen; L Krogius; A Palva
Journal:  J Appl Microbiol       Date:  2004       Impact factor: 3.772
View more
  20 in total

1.  Clostridioides difficile infection in US hospitals: a national inpatient sample study.

Authors:  Daryl Ramai; Khoi Paul Dang-Ho; Chris Lewis; Paul J Fields; Andrew Ofosu; Mohamed Barakat; Ali Aamar; Emmanuel Ofori; Jonathan Lai; Gandhi Lanke; Amaninder Dhaliwal; Madhavi Reddy; James Gasperino
Journal:  Int J Colorectal Dis       Date:  2020-06-17       Impact factor: 2.571

2.  Prevalence and risk factors for asymptomatic Clostridium difficile carriage.

Authors:  Faisal Alasmari; Sondra M Seiler; Tiffany Hink; Carey-Ann D Burnham; Erik R Dubberke
Journal:  Clin Infect Dis       Date:  2014-04-21       Impact factor: 9.079

3.  Evaluation of portability and cost of a fluorescent PCR ribotyping protocol for Clostridium difficile epidemiology.

Authors:  Jonathan N V Martinson; Susan Broadaway; Egan Lohman; Christina Johnson; M Jahangir Alam; Mohammed Khaleduzzaman; Kevin W Garey; Jessica Schlackman; Vincent B Young; Kavitha Santhosh; Krishna Rao; Robert H Lyons; Seth T Walk
Journal:  J Clin Microbiol       Date:  2015-01-28       Impact factor: 5.948

Review 4.  An Update on Clostridium difficile Toxinotyping.

Authors:  Maja Rupnik; Sandra Janezic
Journal:  J Clin Microbiol       Date:  2015-10-28       Impact factor: 5.948

5.  Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013.

Authors:  Isabella A Tickler; Richard V Goering; Joseph D Whitmore; Ashley N W Lynn; David H Persing; Fred C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

Review 6.  Control of Clostridium difficile Infection by Defined Microbial Communities.

Authors:  James Collins; Jennifer M Auchtung
Journal:  Microbiol Spectr       Date:  2017-09

Review 7.  Clostridium difficile infection: epidemiology, diagnosis and understanding transmission.

Authors:  Jessica S H Martin; Tanya M Monaghan; Mark H Wilcox
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-03-09       Impact factor: 46.802

Review 8.  Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections.

Authors:  Jae Hyun Shin; Kevin P High; Cirle A Warren
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-01-25       Impact factor: 6.053

9.  U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.

Authors:  D R Snydman; L A McDermott; N V Jacobus; C Thorpe; S Stone; S G Jenkins; E J C Goldstein; R Patel; B A Forbes; S Mirrett; S Johnson; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

10.  Epidemic Clostridium difficile strains demonstrate increased competitive fitness compared to nonepidemic isolates.

Authors:  Catherine D Robinson; Jennifer M Auchtung; James Collins; Robert A Britton
Journal:  Infect Immun       Date:  2014-04-14       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.